CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St set to open lower as oil jump, high yields fuel inflation concerns
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Citi names 5 top chip picks ahead of Q3 earnings
| (NASDAQ: GDTC) | Delayed: 0.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.98 | 52 Week High | $ | |||
| Open | $0.98 | 52 Week Low | $ | |||
| Day High | $0.98 | P/E | N/A | |||
| Day Low | $0.98 | EPS | $ | |||
| Volume | 1 | |||||
